Entity

Cancer Screening Record

The tracked record of patient eligibility and completion for cancer screenings including colonoscopy, mammography, and lung cancer screening.

Last updated: February 2026Data current as of: February 2026

Why This Object Matters for AI

AI screening program management requires screening history; without records, AI cannot identify overdue patients or navigate follow-up.

Utilization Management & Case Management Capacity Profile

Typical CMC levels for utilization management & case management in Healthcare organizations.

Formality
L3
Capture
L2
Structure
L2
Accessibility
L2
Maintenance
L2
Integration
L2

CMC Dimension Scenarios

What each CMC level looks like specifically for Cancer Screening Record. Baseline level is highlighted.

L0

Cancer screening tracking is entirely informal. Whether patients are eligible for or overdue on colonoscopy, mammography, or lung cancer screening is not documented in any organizational record. Screening decisions are made ad hoc during clinical encounters based on individual provider memory of guidelines and patient history recalled from conversation.

None — AI cannot identify patients due for screening, track screening program compliance, or navigate follow-up for abnormal results because no formal cancer screening records exist.

Create formal cancer screening records — document each patient's screening eligibility with patient identifier, screening type (colonoscopy, mammography, lung CT), eligibility criteria status, last screening date, result, and next due date.

L1

Cancer screening history is tracked in basic patient charts or preventive care logs. Records note screening dates and general results, but eligibility criteria assessment, risk factor documentation, follow-up tracking for abnormal results, and screening interval calculations are inconsistently documented. The log shows past screening events but not whether patients are currently due or what follow-up is pending.

AI can list patients with documented screening history, but cannot identify patients overdue for screening, calculate personalized screening intervals based on risk factors, or track follow-up completeness for abnormal results because records lack consistent eligibility and follow-up documentation.

Standardize screening record documentation — implement structured records with screening type classification, risk factor documentation (family history, genetic markers, exposure history), eligibility determination logic, result categorization (normal, abnormal, inconclusive), follow-up protocol assignment, and interval calculation rules.

L2

Cancer screening records follow standardized documentation: screening type classification, risk factor profiles, eligibility determinations, categorized results, follow-up protocol assignments, and interval calculations. Every patient's screening status is documented consistently. But records are standalone — not linked to the patient's clinical problem list, imaging results, pathology reports, or referral tracking that would enable comprehensive screening management.

AI can identify patients due for screening based on calculated intervals and risk factors. Can generate screening outreach lists. Cannot correlate screening results with diagnostic follow-up completion or track the full screening-to-diagnosis pathway because records are not connected to clinical documentation and results systems.

Link screening records to clinical and diagnostic context — connect each record to the patient's clinical problem list, imaging results, pathology reports, specialist referral tracking, and treatment outcome records.

L3Current Baseline

Cancer screening records connect to clinical and diagnostic context. Each record links to the patient's clinical problem list (cancer risk factors), imaging results (screening findings), pathology reports (tissue analysis results), and specialist referral tracking (follow-up completion). A screening coordinator can query 'show me patients with abnormal mammography results in the past 6 months whose records do not show completed diagnostic follow-up, alongside their risk factor profiles and referral status.'

AI can manage the complete screening lifecycle — identifying eligible patients, tracking screening completion, monitoring abnormal result follow-up, navigating diagnostic workup pathways, and measuring program effectiveness across the patient population.

Implement formal screening record entity schemas — model each screening record as a structured entity with typed relationships to patient clinical records, imaging studies, pathology reports, referral orders, and quality measure benchmarks.

L4

Cancer screening records are schema-driven entities with full relational modeling. Each record links to patient clinical records with risk stratification, imaging studies with standardized finding codes, pathology reports with diagnostic classifications, referral orders with completion tracking, and quality measure benchmarks with performance scoring. An AI agent can navigate from any screening event to the complete clinical, diagnostic, and quality context.

AI can autonomously manage cancer screening programs — generating personalized screening recommendations from risk profiles, monitoring follow-up pathway completion, identifying patients lost to follow-up, and measuring program quality against national benchmarks.

Implement real-time screening event streaming — publish every screening order, result, follow-up action, and quality measurement event as it occurs for continuous screening program intelligence.

L5

Cancer screening records are real-time screening program intelligence streams. Every screening order, imaging result, pathology finding, referral completion, treatment initiation, and quality measurement flows into the record continuously. The record reflects the live state of each patient's screening journey and the program's population-level performance.

Fully autonomous screening program intelligence — continuously monitoring patient eligibility, screening completion, follow-up adherence, and program quality in real-time, managing the cancer screening lifecycle as a comprehensive population health engine.

Ceiling of the CMC framework for this dimension.

Capabilities That Depend on Cancer Screening Record

Other Objects in Utilization Management & Case Management

Related business objects in the same function area.

What Can Your Organization Deploy?

Enter your context profile or request an assessment to see which capabilities your infrastructure supports.